Showing results (1-10 of 822) with videos related to
Sort By:
Pageof 83
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 23, 2003
Emergency contraception--clinical and ethical aspectsA Faúndes, V Brache, F AlvarezHuman Reproduction (Oxford, England)|March 25, 1998
Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant implantsA Faúndes, F Alvarez, V Brache, et al.Contraception|March 1, 1985
Anovulation, inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of Norplant implantsV Brache, A Faúndes, E Johansson, et al.Contraception|February 1, 1986
Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term Norplant useF Alvarez, V Brache, A S Tejada, et al.International Journal of Andrology|April 1, 1981
Sperm suppression with monthly injections of medroxyprogesterone acetate combined with testosterone enanthate at a high dose (500 mg)A Faúndes, V Brache, P León, et al.International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 1, 1981
Sperm migration at different stages of the menstrual cycleA Faúndes, V Montes de Oca, V Brache, et al.Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception|March 1, 1991
Hormonal changes associated with bleeding during low dose progestogen contraception delivered by Norplant subdermal implantsA Faúndes, F Alvarez-Sanchez, V Brache, et al.American Journal of Obstetrics and Gynecology|March 30, 2000
Prevalence of enlarged ovarian follicles among users of levonorgestrel subdermal contraceptive implants (Norplant)F Alvarez-Sanchez, V Brache, V M de Oca, et al.Human Reproduction (Oxford, England)|December 22, 1999
Correlation of endocrine profiles with bleeding patterns during use of Nestorone contraceptive implantsA Faúndes, F Alvarez, V Brache, et al.Expert Opinion on Drug Safety|August 9, 2003
Risk-benefit effects of implantable contraceptives in womenV Brache, A Faundes, F AlvarezPageof 83